Please assess the completion status of the following clinical trial:

Trial Title: Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women, still with uterus, planning total hysterectomy as part of surgical repair for pelvic organ prolapse~* Symptomatic anterior and/or apical vaginal prolapse greater than or equal to Stage 2 (i.e., bulge extends to at least 1 cm of the hymen or beyond)~* Women between 1 and 10 years after menopause. Menopause is defined as one year of amenorrhea or surgical ovariectomy.~* Age 40-70 years old~* No estrogen replacement therapy in the last 1 month~* Physically capable of daily application of vaginal cream~Exclusion Criteria:~* BMI \>35~* Prior surgical repair of prolapse involving the vaginal cuff.~* Prior total hysterectomy~* Premenopausal or postmenopausal \>10 years~* Prior steroid hormone replacement therapy of duration \>1 month (oral or vaginal estrogen, testosterone or corticosteroids)~* History of connective tissue disease (Ehlers-Danlos, Marfan, etc)~* History of vaginal radiation~* Contraindications for estrogen replacement therapy (current, or history of, spontaneous deep vein thrombosis, stroke, coronary artery disease, breast or endometrial cancer)~* Concurrent use of steroid cream for treatment of Lichen sclerosis~* Recent history (within last month) of vaginal infection or vaginitis~* Current tobacco use

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Premarin (Type: EXPERIMENTAL): Premarin cream 0.625mg/1gm. Applied to vagina by applicator as 1gm nightly for 2 weeks then 1gm 2 nights per week for 4-6 weeks or until day of surgery.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo cream, applied to vagina by applicator as 1gm nightly for 2 weeks then 1gm 2 nights per week for 4-6 weeks or until day of surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).